Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(+)-usnic acid | 90.7% inhibition, the most active compound and could be used as a lead compound in developing novel anti-HCV agents. The major amino acid residues of NS3 protease likely involved in the interaction with (+)-usnic acid are Gln41, Ser42, Phe43, His57, Arg10 | Hepacivirus C | |
1-4'-hydroxyphenyl-5-phenyl-2(E)-en-1-pentanone | 56.5% inhibition | Hepacivirus C | |
3beta-O-acetyl-olean-12-en | 29.0% inhibition | Hepacivirus C | |
boceprevir | - |
Hepacivirus C | |
daphneolon | 63.6% inhibition | Hepacivirus C | |
daphneticin | 69.9% inhibition | Hepacivirus C | |
daphnetin | 79.5% inhibition | Hepacivirus C | |
daphnoretin | 36.5% inhibition | Hepacivirus C | |
embelin | - |
Hepacivirus C | |
hydrangetin | 72.5% inhibition | Hepacivirus C | |
additional information | the ethyl acetate extraction of Daphne papyracea exhibits an inhibitory effect towards the HCV NS3/4A protease. Eight compounds are identified from the extract. Molecular docking study of the identified inhibitory compounds against HCV NS3/4A protease using boceprevir as a positive control, docking scores, overview | Hepacivirus C |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Hepacivirus C | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
NS3/4A protease | - |
Hepacivirus C |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Hepacivirus C |